Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,926 | 24,487 | 21,649 | 47,210 | 23,343 |
| Marketable Securities | 44,659 | 54,590 | 68,751 | 46,085 | 68,005 |
| Receivables | 15,000 | N/A | N/A | N/A | N/A |
| Other current assets | 253 | 1,211 | 0 | 390 | 325 |
| TOTAL | $137,236 | $83,608 | $93,186 | $96,506 | $95,096 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 5,805 | 17,601 |
| Other Non-Current Assets | 1,878 | 2,040 | 2,112 | 2,204 | 2,291 |
| TOTAL | $1,878 | $2,040 | $2,112 | $8,009 | $19,892 |
| Total Assets | $139,114 | $85,648 | $95,298 | $104,515 | $114,988 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,622 | 1,622 | 1,216 | 811 | 405 |
| Accounts payable and accrued liabilities | 3,448 | 1,426 | 2,181 | 1,445 | 1,109 |
| Accrued Expenses | 8,720 | 9,399 | 8,604 | 7,846 | 7,455 |
| TOTAL | $22,995 | $12,447 | $12,001 | $10,102 | $8,969 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,901 | 3,293 | 3,685 | 4,077 | 4,485 |
| Deferred Revenues | 9,205 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,390 | 1,422 | 1,137 | 1,215 | 1,291 |
| TOTAL | $8,122 | $4,715 | $4,822 | $5,292 | $5,776 |
| Total Liabilities | $31,117 | $17,162 | $16,823 | $15,394 | $14,745 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 529 | 529 | 313 | 313 | 312 |
| Common Shares | 4 | 3 | 3 | 3 | 3 |
| Retained earnings | -162,104 | -149,313 | -138,169 | -126,768 | -114,895 |
| Other shareholders' equity | -188 | -558 | -873 | -845 | -693 |
| TOTAL | $107,997 | $68,486 | $78,475 | $89,121 | $100,243 |
| Total Liabilities And Equity | $139,114 | $85,648 | $95,298 | $104,515 | $114,988 |